| Document Date: 2014-08-28 09:00:34 Open Document File Size: 333,34 KBShare Result on Facebook
Company InterMune International AG / Innomar Strategies Inc. / Agent InterMune Canada Inc. / / Continent Europe / / Country United States / Canada / Australia / Mexico / / Event FDA Phase / / Facility Laboratory Tests Liver / Laboratory Tests / / IndustryTerm machinery / food / / MedicalCondition General Disorders / chest pain / Nervous System Disorders / Arthralgia / idiopathic pulmonary fibrosis / Dysgeusia / urinary tract infection / nausea / hyperhidrosis / lethargy / angioedema following administration / vomiting / gout / fatigue / Neurologic Dizziness Dizziness / angioedema / Poisoning / Hypersensitivity / Dizziness Somnolence Psychiatric Disorders Insomnia ESBRIET / Increased ALT / end stage renal disease / sinusitis / dizziness / end-stage renal disease / end-stage liver disease / liver disease / Upper Respiratory Tract Infection Injury / Infections / Rash / Influenza / Asthenia Infections / wheezing / Nutrition Disorders / / MedicalTreatment dialysis / / Organization Federal Government / DOSAGE AND ADMINISTRATION / / Position physician / General / / Product Pirfenidone Capsules / vitamin D / Ciprofloxacin / Strength Nonmedicinal Ingredients Oral Capsules / pirfenidone / PIPF-004 / / Technology Geriatrics / dialysis / / URL www.intermune.ca / /
SocialTag |